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ARTICLE

Ly6c+ “inflammatory monocytes”
are microglial precursors recruited
in a pathogenic manner in West Nile
virus encephalitis
Daniel R. Getts,1,2 Rachael L. Terry,1,2 Meghann Teague Getts,1,2
Marcus Müller,3 Sabita Rana,1,2 Bimmi Shrestha,1 Jane Radford,1,2
Nico Van Rooijen,3,4 Iain L. Campbell,2,3 and Nicholas J.C. King1,2
Discipline of Pathology, School of Medical Sciences, 2Bosch Institute, Faculty of Medicine, and 3School of Molecular
and Microbial Biosciences, Faculty of Science, The University of Sydney, Sydney NSW 2006, Australia
4Department of Molecular Cell Biology, Faculty of Medicine, Vrije Universiteit Medical Center, Vrije Universiteit,
1007 MB Amsterdam, Netherlands

In a lethal West Nile virus (WNV) model, central nervous system infection triggered a
threefold increase in CD45int/CD11b+/CD11cⴚ microglia at days 6–7 postinfection (p.i.). Few
microglia were proliferating, suggesting that the increased numbers were derived from a
migratory precursor cell. Depletion of “circulating” (Gr1ⴚ(Ly6Clo)CX3CR1+) and “inflammatory” (Gr1hi/Ly6Chi/CCR2+) classical monocytes during infection abrogated the increase in
microglia. C57BL/6 chimeras reconstituted with cFMS–enhanced green fluorescent protein
(EGFP) bone marrow (BM) showed large numbers of peripherally derived (GFP+) microglia
expressing GR1+(Ly6C+) at day 7 p.i., suggesting that the inflammatory monocyte is a
microglial precursor. This was confirmed by adoptive transfer of labeled BM (Ly6Chi/CD115+)
or circulating inflammatory monocytes that trafficked to the WNV-infected brain and
expressed a microglial phenotype. CCL2 is a chemokine that is highly expressed during WNV
infection and important in inflammatory monocyte trafficking. Neutralization of CCL2 not
only reduced the number of GFP+ microglia in the brain during WNV infection but prolonged the life of infected animals. Therefore, CCL2-dependent inflammatory monocyte
migration is critical for increases in microglia during WNV infection and may also play a
pathogenic role during WNV encephalitis.
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The mechanism resulting in increased numbers
of microglia in the central nervous system
(CNS) during inflammation has long been debated. Microglia have been shown to proliferate in situ in several synthetic inflammatory
models (1–4). In contrast, it is suggested that
microglia can differentiate from blood-derived
precursors that migrate into the CNS; however, recent reports suggest that this can only
occur after radiation-induced “preconditioning”
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of the brain (5–10). Whether viral infection
initiates events resulting in microglial recruitment
from the periphery is unknown.
During embryonic development, microglia
populate the CNS from myeloid lineage precursors in the BM (11). Much is known about early
monocyte lineage precursors, but the differentiation to downstream effector populations in the
adult remain poorly defined. Geissman et al. (13)
have described two major subsets in the peripheral blood, the “inflammatory” and “circulating”
monocyte (12, 14). Inflammatory monocytes express Ly6Chi (Gr1) and the chemokine receptor
© 2008 Getts et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months
after the publication date (see http://www.jem.org/misc/terms.shtml). After six
months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons
.org/licenses/by-nc-sa/3.0/).
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RESULTS
Microglia become activated and increase in number
in response to WNV infection
Sections of brains from C57BL/6 mice infected intranasally
with WNV were labeled with GS-lectin and WNV NS-1 antibody to determine the extent of microglial activation and cellular infection. In normal brains, resting microglia exhibit a
ramified morphology and express few ␣-d-galactose residues on
their cell surface, making them difficult to detect by immunohistochemistry (IHC) with GS-lectin (35). However, upon activation, expression of ␣-d-galactose on microglia increases and
can be readily detected by IHC. Microglia showed prominent
lectin staining in the outer layers of the olfactory bulb on day 3
postinfection (p.i.), corresponding to the appearance of NS-1
2320

staining in this region of the brain (Fig. 1, A and B). Between
days 3 and 7 p.i., the morphology of microglia changed. Early
activated microglia displayed a dendritic morphology and
stained intensely with GS-lectin (Fig. 1 B). However, with progression of infection, as evident by the spread of NS-1 immunoreactivity throughout the brain (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20080421/DC1), microglia with
enlarged cell bodies and retracted processes (stout morphology),
as well as those with amoeboid morphology, including rodshaped and round phagocytic forms, became evident (Fig. 1, C
and D; Fig. S1). Rod-shaped microglia were found predominantly in clusters around neurons or near perivascular cuffs and
resembled previously described perivascular microglia, also
known as Mato cells (Fig. 1, E and F) (36).
Microglia express many markers in common with macrophages. As such, many studies have failed to distinguish correctly between microglia and macrophages. In this study, we
used the positive expression of CD11b in conjunction with
the differential expression of CD45 antigen on the cell surface using flow cytometry, as originally described by Sedgwick
et al. (30). In this way, resting microglia can be differentiated
from activated microglia, as well as from macrophages (26).
Ramified or resting microglia express a CD45lo phenotype,
increasing their cell surface expression to an intermediate
(int) level upon activation. Importantly, activated CD45int
microglia express a lower level of CD45 than macrophages in
the CNS, enabling these two cell types to be differentiated
from each other (30).
As expected, the expression of CD45 on leukocytes isolated
either from mock-infected mouse brains or at day 0 p.i. was
uniformly low (resting microglia [references 26, 30]; Fig. 1 G
and not depicted). By day 7 p.i., brains infected with WNV displayed a heterogenous CD45 versus CD11b profile. Relatively
few CD45lo microglia were present, whereas a CD45int (activated microglia) population was present and could be distinguished from a significant population of CD11b+/CD45hi
macrophages (Fig. 1 H). The increase in CD45 expression on
microglia is indicative of activation of these cells. Analysis of
Ly6G and Ly6C expression on these resting and activated microglia (Fig. 1, I and J) showed a significant increase in Ly6C expression on CD45int microglia. The absence of Ly6G expression
confirms that these cells are not granulocytes.
Enumeration of microglia by flow cytometry showed that
WNV infection resulted in an increase in the absolute number
of CD45int microglia (Fig. 1, H and K). Overall microglial cell
numbers (CD45lo+int) were not statistically different until day 7
p.i. By day 7 p.i., the total numbers of microglia increased by
three- to fourfold (Fig. 1 K). The differential contributions
of resting and activated microglia are also shown in Fig. 1 K.
CD45int cells, virtually absent on day 0 p.i., were found in low
numbers on day 3 p.i., correlating with the increase in lectin labeling by IHC. Numbers of CD45int microglia had increased
significantly by day 7 p.i. In contrast, numbers of CD45lo microglia had significantly decreased at day 6 compared with day 3
p.i. and were significantly lower than CD45int microglial numbers at day 7 p.i. Because numbers of total microglia at day 6
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CCR2 (12–14). CCR2 and one of its ligands, CCL2, are evidently important in both emigration of these monocytes from
the BM and their immigration into inflamed tissues (15, 16). Inflammatory monocytes migrate to the spleen and skin, where
they can differentiate into macrophages and Langerhans cells,
respectively (6, 13, 17). Circulating monocytes, identified by
their low expression of Ly6C in conjunction with CX3CR1, are
thought to be important in replenishing tissue macrophages during homeostatic conditions (12).
In this study, we have used West Nile virus (WNV) to investigate the in vivo trafficking and differentiation of monocyte/microglia during lethal encephalitis. Although it is clear
from previous work that several elements of the systemic immune system work together during WNV infection to control
viral growth and dissemination (18–20), it is also apparent that
infiltrating CD11b+/CD45+ myeloid cells contribute to underlying immunopathology observed during WNV encephalitis (21, 22). Although activated microglia have been observed
during WNV infection of the brain (19, 23), the contribution
of microglia to immunopathology is unknown. Microglia are
immune-competent cells of the CNS, comprising up to 20%
of the total rodent glial population (24). Resting microglia
usually exhibit a ramified dendritic morphology and express
low levels of cell surface immune molecules. However, alterations in the microenvironment can result in rapid activation.
Activated microglia acquire an amoeboid morphology
(25–28), develop an increase in phagocytic ability, exhibit enhanced migratory capacity within the brain, and increase their
expression of cell surface glycoproteins including CD45 and
MHC-II (26, 29–34).
In this paper, we show for the first time in nonirradiated
mice that Ly6Chi inflammatory monocytes migrate in a CCL2dependent fashion into the WNV-infected CNS, where they
develop a microglial phenotype. Inhibition of microglial immigration seen after CCL2 neutralization correlated with
enhanced survival of WNV-infected mice. Paradoxically, the
titer of WNV in the CCL2-neutralized brains was similar
to that observed in nontreated mice, indicating that pathogenesis is not directly related to viral load and implicating
CCL2-mediated microglial migration in the pathogenesis of
WNV encephalitis.
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p.i. were not significantly different from those of the earlier time
points, this suggests that resting microglia are increasing their
CD45 expression (as previously described); however, the significant increase in overall microglial numbers in the brain by day 7
in WNV infection argues that there is either in situ microglial
proliferation or external recruitment.
JEM VOL. 205, September 29, 2008

Microglia do not proliferate significantly in situ
after WNV infection
As mentioned, several stimuli may induce microglial proliferation, which is measurable by nuclear BrdU incorporation
(1–4, 9, 33, 34, 37, 38). However, in some of these studies,
mice were exposed to BrdU for several days. This makes it
2321
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Figure 1. Kinetics of microglial change during WNV infection. WNV NS-1 protein first appeared in the outermost layer of the olfactory bulb on
day 3 p.i. (A, arrowheads). Early activated microglia, identified by lectin staining and dendritic morphology, were concurrently detected in the outermost
layer on day 3 p.i. (B, arrowheads and enlarged inset of the arrowed box) but nowhere else in the brain. On days 6 and 7 p.i. (C and D), scattered activated
microglia (arrows and enlarged inset of the arrowed box) exhibited both amoeboid and intermediate activated morphology in the olfactory bulb. In the
brain parenchyma, lectin-positive cells with amoeboid morphology (arrows and enlarged insets of arrowed boxes) were observed surrounding the blood
vessels on days 6 (E) and 7 (F) p.i. Bars, 100 μM. Flow cytometry of leukocytes isolated from the whole brain in mock infected (G) showed a predominant
population of resting microglia with a classical CD45lo phenotype (R1). By day 7 p.i., significant numbers of activated microglia could be identified by their
CD45int expression, as indicated by R2 (H). Analysis of the total microglial population for Ly6G (I) and Ly6C (J) expression showed increased Ly6C expression on activated microglia but no Ly6G expression on resting or activated microglia. Enumeration of total microglia at days 0, 3, 5, 6, and 7 p.i.
showed a major increase between days 6 and 7 p.i. (K). Increased numbers of CD45int (activated) microglia could be detected as early as day 3 p.i. (K), with
numbers increasing dramatically between days 5 and 7. These changes were temporally independent of decreases in CD45lo (resting) microglial numbers,
which declined from day 3 p.i. onwards. Data shown are means ± SD and are representative of three experiments with at least three mice per group. ***,
P < 0.001, comparing day-7 p.i. CD45lo with day-7 p.i. CD45int; ###, P < 0.001, comparing day-7 p.i. total microglia with days 0, 5, or 6 p.i. using one-way
analysis of variance (ANOVA) with a Tukey-Kramer posttest.
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Microglial increases are not caused by breakdown
of the blood-brain barrier (BBB)
Breakdown of the BBB may explain the significant burst
in numbers of microglia seen in the WNV-infected mouse
brain between days 6 and 7 p.i. We investigated the status of
the BBB by fibrinogen IHC in the WNV-infected brain at
the peak of disease (day 7 p.i.). The presence of fibrinogen has
previously been described to detect microvascular leakage in
the brain during several distinct neuroinflammatory models
and on postmortem brain tissue (39–44). Although all mice
infected with WNV had severe leukocyte infiltration and
perivascular cuffing, 70% of infected mice (7/10) displayed
no detectable fibrinogen immunoreactivity (Fig. 2, J–L),
whereas fibrinogen staining in the remaining mice was extremely scant and limited to the luminal side of the endothelium (Fig. 2, M–R). In addition, administration of Evans blue,
1 h before sacrifice on day 7 p.i., showed that BBB breakdown
was similarly sporadic, with two out of six mice showing
some Evans blue leakage into the brain (Fig. S3, available at
http://www.jem.org/cgi/content/full/jem.20080421/DC1).
Therefore, similar to other routes of WNV infection (45),
the intranasal route of WNV infection causes sporadic
BBB breakdown.
Microglial numbers are reduced in monocyte-depleted
WNV-infected mice
Microglial infiltration into the brain has been suggested to occur in several models; however, this has not been addressed
during viral encephalitis. Recruitment from the peripheral
2322

blood to sites of infection in organs other than the brain and
their differentiation into effector cells has been shown to involve Ly6C+ or Gr1hi monocytes (13, 14, 46). Interestingly,
31.3 ± 7% of activated microglia expressed Ly6C in WNVinfected mice, compared with 12 ± 0.8% in mock-infected
control mice (P < 0.001). Furthermore, 7.6 ± 1.5% of resting
microglia expressed detectable Ly6C in infected mice, compared with 0.32 ± 0.2% in mock-infected control mice (P <
0.001). To determine whether blood-derived monocytes are
microglial precursors during WNV infection, we depleted
blood monocytes with clodronate-loaded (C-L) liposomes. It
has previously been shown that liposomes do not deplete macrophages in the brain parenchyma (47, 48). Although perivascular cuffs were evidently resistant to C-L liposome depletion
in WNV-infected mice (Fig. 3, A–L), we additionally used Dillabeled (D-L) liposomes to further confirm visually that liposomes do not have access to the CNS during WNV infection
(Fig. 3, M–X and top right insets). After injection, D-L liposomes were abundantly localized to the splenic marginal zones
in both infected and mock-infected mice (Fig. 3, M–T). In
contrast, no D-L liposomes were found in the brains of either
day-7 WNV-infected mice (Fig. 3, U–X) or mock-infected
mice (Fig. 3 X, bottom left inset), confirming that liposomes do
not cross the BBB. This further supports the data in the previous section, indicating that little or no BBB breakdown occurs
in this model. Overall, these data support previously published
reports and indicate that this method of depletion primarily affects peripheral monocyte populations, especially the inflammatory monocyte compartment (Fig. S4, available at http://www
.jem.org/cgi/content/full/jem.20080421/DC1) (49).
Clodronate liposome treatment of WNV-infected mice
1 d before infection and then every other day onwards resulted in significantly reduced numbers of microglia in the
brain, as detected using flow cytometry, on day 7 p.i., compared with WNV-infected mice without treatment or treated
with nondepleting null liposomes (Fig. 3 Y). As C-L liposomes do not delete any myeloid cells behind the BBB but
cause a significant reduction in the number of microglia in
the brain, this strongly suggests that the increased numbers
of microglia in the brain in WNV encephalitis are derived
from blood monocytes.
Increased microglial numbers in WNV infection are derived
from the blood
To further investigate possible microglial precursors during
WNV infection, we used the cFMS-EGFP mouse. cFMS
is the colony stimulating factor receptor 1, CD115, and is
largely restricted to cells of the macrophage lineage (50).
Microglia in the normal brain are mostly quiescent and
thus radio resistant. Therefore, chimeric mice were made, in
which BM from C57BL/6-7.2fms-EGFP transgenic (CD45.2)
mice was used to reconstitute ␥-irradiated C57BL/6 congenic
B6.SJL-PtprcaPep3b/BoyJ (CD45.1) mice (Fig. S5, A–C, available at http://www.jem.org/cgi/content/full/jem.20080421/
DC1). This chimera allowed us to differentiate between
resident (GFP⫺) and infiltrating (GFP+) microglia (50).
LY6CHI MONOCYTES BECOME MICROGLIA IN ENCEPHALITIS | Getts et al.
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impossible to exclude the possibility that BrdU+ microglia in
these models arose from precursor cells that had proliferated
in peripheral sites, such as the BM, and subsequently migrated
to the brain. Therefore, groups of WNV-infected mice were
pulsed i.v. with BrdU for 3 h on either day 6 or 7 p.i., when
maximal increases in microglia were occurring, and killed
immediately after the pulse period.
In WNV-infected mice on either day 6 or 7 p.i., the frequency of BrdU+ cells was low. Of the total BrdU+ cells
counted in brain sections from infected mice, >70% were localized within perivascular cuffs on both days 6 and 7 p.i., with
very few observed in the brain parenchyma (Fig. 2, A, B, and D).
Labeling in day-7 p.i. WNV-infected mice not treated with
BrdU (Fig. 2 C) or in BrdU-treated mock-infected mice (not
depicted) showed virtually no positively labeled cells in any areas of the brain (Fig. 2 D). This was further supported by flowcytometric analysis, which showed that ⵑ1% of microglia in
WNV infection were BrdU+ at day 7 p.i. (Fig. 2, E and F; and
Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20080421/DC1). The combination of the very low frequency of BrdU+ microglia in WNV-infected mice, their predominantly perivascular location during the period of greatest
increase in activated microglia, and the relatively small reduction in absolute numbers of resting microglia (Fig. 1 K) makes
it unlikely that in situ proliferation can account for the large
numbers of activated microglia seen at day 7 p.i.
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Figure 2. There is little cellular proliferation and negligible BBB disruption during WNV encephalitis. Mice were treated with BrdU for 3 h before sacrifice. Routine IHC for BrdU showed that BrdU+ cells localized predominantly to the perivascular cuff on days 6 (A) and 7 (B) p.i. This was not seen
in mock-infected mice or mock BrdU-treated WNV-infected mice (C). Enumeration of BrdU+ cells on histological sections showed that >70% of all BrdU+
cells were perivascularly localized (D). The percentage of proliferating microglia was also determined by flow cytometry (E and F). Approximately 1% of
microglia in WNV-infected and mock-infected mice were seen to be BrdU+ (E and F). To test the status of the BBB, fibrinogen IHC was performed on 10
WNV-infected mice and 5 mock-infected mice. Fibrinogen was not detected in any mock-infected mice at day 7 p.i. (0/5; G–I). Furthermore, 7/10 WNVinfected mice also failed to exhibit any evidence of fibrinogen leakage (J–L). In the three mice where fibrinogen labeling was detected, staining was scant
and limited to the luminal surface of vessels (M–O, 20×; P–R, 100× images of M–O). Data shown are means ± SD. Data from BrdU experiments are representative of two experiments with at least five mice per group. Bars: (A–C) 100 μM; (G–O) 200 μM; (P–R) 50 μM.
JEM VOL. 205, September 29, 2008
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Figure 3. C-L liposomes do not enter the WNV-infected CNS. Liposomes loaded with clodronate were injected i.v. at day 7 p.i. and, 6 h later, mice
were killed. Hematoxylin and eosin (H&E) staining of brain sections showed no perivascular cuffing in mock-infected animals (A and B). In contrast,
distinct perivascular cuffs were observed in the WNV-infected C-L liposome–treated group (E and F) and the WNV-infected PBS liposome-treated group
(I and J). To confirm that the cells within these cuffs were of myeloid lineage, we stained sections, consecutive to those stained with H&E, with lectin.
Lectin staining in brain sections from mock-infected mice confirmed the absence of perivascular cuffing (C and D). In contrast, most of the cells within
2324
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Adoptively transferred Ly6chi, not Ly6Clo, cells traffic
to the CNS within 12 h of transfer
It has previously been reported that the ability of inflammatory
monocytes to penetrate the CNS in chimeric mice is caused
by irradiation preconditioning of the CNS. Therefore, be-

cause there was negligible breakdown of the BBB in this viral
model, we further investigated the ability of inflammatory
monocytes to penetrate the CNS using tracking techniques
in nonirradiated mice.
First, we tested the ability of inflammatory monocytes
(Ly6Chi/CD11b+/cFMS-EGFP+{CD115+}) and circulating
monocytes (Ly6Clo/CD11b+/cFMS-EGFP+{CD115+}) to
traffic to the CNS. To do this, we adoptively transferred
106 EGFP+/CMTMR–cell tracker orange+ BM-derived inflammatory monocytes (Ly6Chi) together with 106 EGFP+/
CMTMR–cell tracker orange⫺ BM-derived circulating monocytes (Ly6Clo) at day 6.5 p.i. (Fig. 5, A–D). 12 h later, the
presence of these cells in the brain was investigated using flow
cytometry (Fig. 5, E–I). Although recovery of adoptively
transferred cells was low, the number of EGFP+ cells in the
brain was significantly greater in the WNV-infected animal
(Fig. 5 F, 0.03%) than in the mock-infected mouse (Fig. 5 G,
0.005%). Cell tracker orange+ GFP+ Ly6Chi cells comprised
>90% of adoptively transferred cells isolated from the brain
(Fig. 5 I). Interestingly, both CD45int- and CD45hi-expressing
GFP+ cells were isolated from the WNV-infected brain (Fig.
5 H), suggesting that Ly6Chi precursors may differentiate into
either microglia or macrophages. This was also seen when we
transferred GFP+ Ly6Chi and GFP+ Ly6Clo monocytes separately into mock-infected mice (Fig. 5, J and L–N) or WNVinfected mice at day 6 p.i. (Fig. 5, K and O–Q).
As a second test to confirm the role of inflammatory monocytes as microglial precursors during WNV encephalitis, we
used an in vivo bead labeling system that was previously described (51, 52). Using clodronate liposome depletion at day
5.5 p.i. with FITC polystyrene bead injection 12 h later, we
were able to recapitulate the stable labeling of circulating
Ly6Chi inflammatory monocytes in WNV-infected mice (Fig.
6, A–F), as was previously described in uninfected mice (14,
51). In brief, injection of FITC beads alone into WNVinfected mice at day 6 p.i. resulted in the stable labeling of
GR1lo monocytes in the circulation (Fig. 6, B and D). In contrast, prior C-L liposome–mediated depletion before bead infusion resulted in stable labeling of GR1hi or inflammatory
monocytes (Fig. 6, C and E).
Flow cytometric examination of the WNV-infected brain
at day 7 p.i. in mice where inflammatory monocytes were labeled with beads after C-L liposome treatment revealed a strong
bead+/CD45int/CD11b+/CD11c⫺ population of microglia
(Fig. 6 J), which was absent in non–bead-treated (Fig. 6 H)

the perivascular cuff were lectin+ in both the WNV-infected C-L liposome–treated (G and H) and the PBS liposome-treated (K and L) groups. To further
ensure that C-L liposomes used to deplete circulating monocytes did not enter the brain, we injected D-L liposomes at day 7 p.i. Dil was found in the
marginal zones of mock- (M–P) and WNV (Q–T) -infected mouse spleens. However, no D-L liposomes were found in the WNV-infected brain (U–X) or
the mock-infected brain (X, bottom left inset). Top right insets are higher power views of cells in representative fields. Depletion of monocytes from the
blood compartment with C-L liposomes from 1 d before infection and then every other day onwards resulted in a significant reduction in the numbers
of microglia in WNV-infected mice compared with WNV-infected mice treated with null liposomes or mock-treated, as detected by flow cytometry (Y).
Data shown are from at least three mice per group and are representative. C-L liposome depletion data are means ± SD and are representative of three
experiments with at least three mice per group. *, P < 0.05 using a two-tailed T test. Bars: (A, C, E, G, I, K, and M–X) 200 μM; (B, D, F, H, J, L, and insets)
50 μM.
JEM VOL. 205, September 29, 2008
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Histological examination revealed that both GFP+ perivascular macrophages (Fig. 4 A, white arrow) and GFP+ parenchymal ramified microglia (Fig. 4 B) accounted for a small
percentage of cells in the mock-infected brain, which is consistent with previous work (Fig. 4, G and H) (7). Similar to
C57BL/6 mice, WNV-infected chimeric mice developed
encephalitis and were moribund by day 7 p.i. (unpublished
data). WNV-infected cFMS-EGFP chimeras displayed numerous GFP+ cells in all regions of the brain by day 7 p.i. (Fig. 4,
C and D). Of particular note, the distribution of these GFP+
cells was mostly within perivascular cuffs (Fig. 4 C and inset).
In addition, cells nearest the center of the perivascular cuff
appeared to have a round monocytic morphology (Fig. 4 C, inset, white arrow), whereas those nearer to the brain parenchyma on the periphery of the perivascular cuffs were more
rod shaped (inset, red arrow), suggesting monocyte differentiation as cells enter the parenchyma.
Flow cytometric analysis at day 7 p.i. confirmed that at
least 50–75% of activated microglia (CD45int/CD11b+/CD11c⫺)
expressed GFP, indicating that they were peripherally derived (Fig. 4, E and G). Furthermore, at this time point,
75% of these activated GFP+ microglia also expressed the inflammatory monocyte-associated Gr1 (Ly6C; Fig. 4, F and I).
In contrast, most resting microglia (CD45lo/CD11b+/CD11c⫺)
from both mock-infected and WNV-infected chimeras were
GFP⫺, indicating that they were of resident origin (mock
infected, 93 ± 3.0%; WNV-infected, 88 ± 3.9%; Fig. 4 H).
Adding together the data in Fig. 4 (G and H, right), it can
be seen that the total number of GFP⫺ microglia (i.e., activated and resting) in WNV-infected mice was not significantly different from the total number of GFP⫺ microglia
in mock-infected mice. This suggests that proliferation of
microglia in situ in the brain is unlikely to be the major
mechanism for increased microglial numbers during WNV
encephalitis. Furthermore, the proportion of GFP+ CD45int
microglia expressing GR1 in the WNV-infected mouse
supports the differentiation of these microglia from a bloodderived precursor, specifically the GR1-expressing inflammatory monocyte.

Published September 8, 2008

and bead-only–treated WNV-infected controls (Fig. 6 I). This
data clearly suggests that the migration of bead+ blood monocytes into the brain and subsequent differentiation into microglia is a very rapid event. As this has not been described,
and to ensure that these CD45int/CD11b+ bead+ cells isolated
from the brain were not just recently migrated nondifferentiated blood monocytes, we compared the expression of GR1,
MHC-II, and the costimulation molecule CD86 on bead+ CD45intCD11b+ brain microglia and bead+ inflammatory mono2326

cytes in the circulation (Fig. 6, I–K). The pattern of GR1
expression on bead+ microglia was decreased, compared with
circulating bead+ inflammatory monocytes, suggesting that
Ly6C is down-regulated when monocytes enter the inflamed
CNS (Fig. 6 K). Levels of both MHC-II and CD86, in contrast, were higher on bead+ microglia compared with bead⫺ or
bead+ circulating inflammatory monocytes (Fig. 6, L and M).
These adoptive transfer and bead-tracking experiments demonstrate the traffic of inflammatory monocytes in nonirradiated
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Figure 4. Histology and flow cytometry of WNV-infected cFMS-EGFP chimeras. Reconstitution of ␥-irradiated C57BL/6 congenic B6.SJL-PtprcaPep3b/BoyJ (CD45.1) mice with cFMS-EGFP BM resulted in chimeras in which a small number of GFP+ cells were present in the CNS of mock-infected
mice. Histologically, GFP+ cells (white arrowheads) were usually seen around the perivascular space (A); however, a small number of ramified microglia
expressing GFP were seen in the parenchyma (B). During WNV infection, a large influx of GFP+ cells was seen, in most cases located to the perivascular
cuff (C, 20× magnification). Insets (100× magnification of the same field) show recruited round GFP+ cells near the vessel lumen (white arrowhead) and
rod-shaped GFP+ cells closer to the parenchyma (red arrowhead). Gr1 (D, red) staining of chimeras clearly showed several Gr1+/cFMS+ cells in the brain
(D, yellow). Using flow cytometry (E), it was clear that a large proportion of GFP+ cells were CD45int microglia (R2) and CD45hi macrophages (blue dots), as
well as Gr1+ (F). Significantly more (approximately fourfold) CD45int microglia were GFP+ at day 7 p.i., compared with mock-infected mice (G), whereas
there were significantly fewer GFP⫺ CD45lo resting microglia at day 7 p.i., compared with mock-infected mice (H). Significantly more (at least fourfold)
GFP+ CD45int microglia were Gr1+ at day 7 p.i., compared with mock-infected mice (I). Gr1 data shown are means ± SD and are representative of four
experiments with at least three mice per group (***, P < 0.001, two-tailed unpaired t test). Bars: (A and D) 200 μM; (B and C) 100 μM; (insets) 50 μM.
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Figure 5. Adoptively transferred Ly6Chi monocytes traffic into the WNV-infected CNS. Ly6Chi/CD11b+/GFP+ and Ly6Clo/CD11b+/GFP+ BM cells
were sorted as shown (A–C) from day 6 WNV-infected cFMS-EGFP transgenic mice. Ly6Chi monocytes were labeled as described in Materials and methods
with CTMR–cell tracker orange (D). A 1:1 ratio of Ly6Chi/Ly6Clo cells was intravenously injected into WNV-infected mice on day 6.5 p.i. or into mock-infected mice, whereas some mice received no cells. Leukocytes were isolated from the brains of these WNV-infected mice receiving no cells (E) and from
WNV-infected (F) and mock-infected (G) brains 12 h after transfer. GFP+ cells were only found in the CNS of WNV-infected mice (F), with the adoptively
transferred cells expressing differential levels of CD45 (H) as indicated by markers M1 (CD45int) and M2 (CD45hi). More Ly6Chi (GFP+/CTMR cell tracker
orange+) BM cells were found to track to the WNV-infected brain than Ly6Clo (GFP+/CTMR–cell tracker orange⫺) BM cells (I). This was also observed when
we injected these populations of cells separately into mock-infected (J and L–N) or WNV-infected mice (K and O–Q). Data are representative of two experiments with at least four mice per group. Bars, 50 μM.
JEM VOL. 205, September 29, 2008
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Figure 6. Bead-labeled inflammatory monocytes, not GR1lo monocytes, traffic into the WNV-infected brain. As a second method for trafficking monocytes, we stably labeled peripheral Ly6Chi monocytes, as previously described (14, 51) (A–F). WNV-infected mice receiving no FITC beads had no
circulating bead+ cells (A). WNV-infected mice that received only beads with no prior macrophage depletion with C-L liposomes only had beads inside
Ly6Clo monocytes (R2B; B and D). In contrast, C-L liposome depletion in WNV-infected mice before bead injection resulted in the labeling of Ly6Chi inflammatory monocytes (R2C+B; C, E). The successful labeling of Ly6Chi versus Ly6Clo is confirmed by overlaying R2B and R2C+B (F). Finally, when we looked for
the presence of beads in microglia (gated as shown in G) in WNV-infected mice, we found none in the non–bead-treated group (H) or the group in which
Ly6Clo peripheral monocytes were labeled with beads (I). However, in WNV-infected mice where we labeled the Ly6Chi monocyte population with beads
2328
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mice and show clearly that the large burst of microglial numbers seen in the WNV-infected brain is caused by the recruitment of inflammatory monocytes and is not the result of
radiation-induced changes in the CNS. Furthermore, these
data show that inflammatory monocyte differentiation into
microglia may occur in a shorter time frame than originally
considered (12, 34).

CCL2 neutralization prolongs survival
In initial CCL2 neutralization experiments, neutralized mice
displayed reduced disease-induced behaviors, including seizures, piloerection, and hunching (unpublished data). Treatment of infected mice with neutralizing antibody over several
days resulted in significantly prolonged survival time, compared
with infected mice receiving either isotype antibody or PBS
alone (Fig. 8 E). Importantly, CCL2 neutralization had no effect on the titer of WNV in these mice, despite their increased
survival (Fig. 8 F). This indicates that the immigrating Ly6Chi
microglia arising from the BM are pathogenic in WNV encephalitis. Importantly, these data also discount a role for these
cells in dissemination of WNV to the brain in this model.
DISCUSSION
The role of monocyte trafficking as a mechanism for microglial cell replenishment has been debated for some time. This
has been fueled by the inability to identify microglia from
other macrophage populations found in diseased brains. Using several methods, we have highlighted a critical role for
peripheral Ly6Chi inflammatory monocytes and the chemokine receptor ligand CCL2 in the ontogeny of microglia during fatal WNV infection of the brain.
Although it is often argued that microglial proliferation is the
mechanism behind increased microglial cell numbers seen during
CNS inflammation, the low level of proliferation observed during
WNV infection in conjunction with the ability of peripheral depletion of both classical and circulating monocytes to significantly
reduce the numbers of microglial cells in WNV-infected brains at
day 7 p.i. suggest that the recruitment of a peripheral microglial
precursor plays an important role in WNV encephalitis.
The peripheral blood contains two monocyte subsets, the
inflammatory and circulating monocytes (6, 13, 14, 17, 46, 49,
51). Inflammatory monocytes are distinguished from circulating
monocytes by their differential expression of the Ly6C portion
of the Gr1 complex (6, 13, 17, 49). The similar expression of
Ly6C on several CD45int microglia isolated from the WNVinfected brain implicates inflammatory monocytes as a microglial precursor pool (13, 14, 49).

after C-L depletion, we found microglia-containing FITC beads (J). Furthermore, bead+ microglia showed down-regulated GR1, compared with bead+ inflammatory monocytes (K), suggesting down-regulation upon entry in to the CNS. Finally, these bead-labeled monocyte-derived microglia had also
up-regulated their expression of MHC-II (L) and CD86 (M) upon entry into the brain.
JEM VOL. 205, September 29, 2008
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WNV infection triggers CCL2 production, which attracts
inflammatory monocyte, microglial precursors
CCL2 has been implicated in the egress of monocytes from
BM (15, 16). We hypothesized that CCL2 may be involved in
this process during WNV infection. Intranasal WNV infection
of the CNS triggered the secretion of substantial amounts of
CCL2 protein in the brain, beginning on day 5 and increasing
until the time of death (Fig. 7 A). The kinetics of these high
brain levels were mirrored by much lower levels in the serum
(Fig. 7 A). Message for this chemokine is shown in Fig. 7 B (i)
near perivascular cuffs by CCL2 mRNA in situ hybridization
in the brain. Labeling for CCL2 protein in WNV-infected
brains confirmed the presence of CCL2 protein at the perivascular cuff. However, costaining for viral antigen (NS-1), lectin,
and CCL2 protein showed that many, though not all, virusinfected neurons and some uninfected neurons were CCL2+,
whereas only occasional microglia were CCL2+, suggesting that
viral-infected neurons are a major source of CCL2 during
WNV infection (Fig. 7 B, ii–v).
The data in the previous paragraph suggest that the CNS was
the source of the serum CCL2 and that this induced the egress
and observed migration of BM monocytes to the CNS. To test
this, we injected CCL2-neutralizing antibody to inhibit both
BM egress and CNS trafficking in cFMS-EGFP chimeras. Fig.
7 C shows a statistically significant reduction in the number of
GFP+/CD11b+/CD45int (reduced to 31%) and CD45lo (reduced
to 29%) immigrating microglia isolated from the CNS on day 7
p.i. after CCL2 neutralization, compared with isotype antibodytreated WNV-infected mice. This indicates that a major factor in
the immigration of microglia is CCL2. This was not attributable
to irradiation because nonirradiated WNV-infected mice (Fig. 7,
D–G) also showed a reduction of up to 50% of total microglial
numbers (Fig. 7 G). This reduction was mostly accounted for by
the reduction of Ly6Chi microglia to ⵑ20% of the levels seen in
control isotype antibody-treated mice (Fig. 7 G).
This was further reflected in chimeric mice by the analysis
of GFP+/CD11b+ monocytes in the blood and BM, using
the gating strategy illustrated (Fig. 8, A–C). As expected, in the
BM, significantly more Gr1hi cells were retained in the CCL2neutralized compared with the isotype antibody–treated mice,
whereas Gr1lo cells were not statistically different between
these groups (Fig. 8 D, right), confirming previous studies
(15). However, CCL2 neutralization significantly increased

the GR1hi cell numbers in the blood but had little effect on
the GR1lo monocyte numbers (Fig. 8 D, left). Thus, Gr1hi
cells are evidently inhibited from immigrating into the brain in
CCL2-neutralized WNV-infected mice, both at the level of
the BBB and during egress from the BM. In contrast, over this
short period of time (12 h), no changes were observed in blood
and BM monocyte compartments after CCL2 neutralization
of mock-infected mice (Fig. S6, available at http://www
.jem.org/cgi/content/full/jem.20080421/DC1). This data
indicates the importance of CCL2 in the trafficking of microglia
from the BM to the brain during WNV encephalitis.
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Figure 7. CCL2 protein kinetics and neutralization during WNV infection. Using a multiplexed cytokine bead array, we measured both the serum
and brain levels of CCL2. The level of CCL2 protein increased throughout infection in both brain and serum (A). CCL2 mRNA in the brain of five WNVinfected mice on day 7 p.i. was often localized to perivascular cuffs (B, i, black arrowheads). Fluorescent antibody labeling for CCL2 protein (red) and NS-1
(blue) showed that most cells expressing CCL2 were infected neurons (B, ii–iv; ii, white arrowheads). Not all infected neurons expressed CCL2 (B, ii and iii,
white outlined arrowheads) and some uninfected neurons expressed CCL2. (B, v, white outlined arrowheads). The addition of lectin staining (green; B,
iii–iv) showed that occasional perivascular microglia also expressed CCL2 faintly (B, iv, white arrowhead), whereas most microglia evidently did not
(B, iii and v, white arrowheads). CCL2 in WNV-infected EGFP-cFMS chimeras was neutralized with intraperitoneal CCL2-neutralizing monoclonal antibody,
resulting in a significant reduction in immigrant (GFP+) microglia at day 7 p.i. (C). We also determined whether this was also observed in nonirradiated
mice (D–G). In nonirradiated WNV-infected mice, CCL2 neutralization (F) resulted in significantly reduced numbers of microglia, accounted for by drastic
reduction in Ly6Chi-expressing cells (G), which was not observed in mock- (D) and WNV (E) -infected mice. Data shown are means ± SD and are representative of at least two experiments with at least three mice per group. CCL2 broad array data are representative of three different experiments with at least
three mice per group. Statistical analysis of CCL2 protein data was conducted using one-way ANOVA with a Tukey-Kramer post test. Neutralization experiments were analyzed using a two-tailed unpaired t test comparing neutralized to nonneutralized WNV infected mice. *, P < 0.05; ***, P < 0.001. Bars:
(B, i) 200 μM; (B, ii–iv) 50 μM.

BM chimeras have been successfully used to monitor microglial behavior in several disease models and allow for the
differentiation of resident and immigrant microglia (5, 7, 8).
However, these studies relied on the expression of ␤-actin in
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donor BM in conjunction with IHC directed against antigens such as CD11b and IBA-1 (5, 8). As these antigens are
expressed equally in macrophages and microglia, definitive
identification of microglia and distinction from macrophages
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Figure 8. CCL2 neutralization sequesters Gr1hi monocytes in the BM and blood of WNV-infected mice and prolongs the life of WNV-infected animals. Monocyte populations in the BM (BM-derived monocyte) and peripheral blood (peripheral blood monocyte) were investigated by flow
cytometry, based on the expression of EGFP-cFMS in conjunction with a cocktail of antibodies, including CD11b and CD45, using gating strategies indicated in A, B, and C. CCL2 neutralization in WNV-infected EGFP-cFMS chimeras resulted in significant increases in Gr1hi (inflammatory monocytes) in
both the BM and peripheral blood (D), as well as significantly prolonging the life of WNV-infected mice (E), compared with WNV-infected mice either
treated with isotype control mAb or PBS during infection. Plaque assays (F) showed that CCL2 neutralization had no significant impact on the viral titer
on day 7 p.i. Data shown are means ± SD and are representative of two different experiments with four mice per group. Neutralization experiments were
analyzed using a two-tailed unpaired t test comparing neutralized to nonneutralized WNV-infected mice. *, P < 0.05; ***, P < 0.001. Kaplan-Meyer survival
curves are representative of the results of two separate experiments with 10 mice per group in each. Data were analyzed using Prism Chi test (P < 0.001).

during inflammation is impossible. In the present study, BM
from mice expressing EGFP on the cFMS promoter (CD115)
were used as donors for chimeras. In conjunction with flow
cytometry staining for CD45 antigen, this allowed us not only
JEM VOL. 205, September 29, 2008

to delineate between resident (GFP⫺) and immigrating (GFP+)
myeloid cells but also definitively to distinguish between CD45hi
macrophages and CD45lo/int microglia (29, 50, 53). Infected
cFMS-EGFP chimeras displayed widespread leukocyte
2331
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Table I.

Antibodies used in this study

Antibody

Method

WNV-NS-1-biotin+

Source

IHC

1:100

GS-lectin-biotin+/FITC
CD11b-APC/PE/APC-CY7/Alexa-700

IHC
FC

1:50
1:100

CD45-PerCP
Ly6C-FITC/ Biotin
Ly6G-PE
GR1-biotin/APC-Cy7/ Pacific blue

FC
FC
FC
FC/IHC

1:100
1:100
1:100
1:100

CD11c-biotin+/PE-Cy7

FC

1:150

CCL2-LEAF
CD115-PE

Neut
FC

R. Hall (University of Queensland,
Brisbane, Australia)
Sigma-Aldrich
BD Biosciences/
BioLegend
BD Biosciences
BD Biosciences
BD Biosciences
BD Biosciences/
BioLegend
BD Biosciences/
Biolegend
BioLegend
eBioscience

100 μg per mouse
1:50

Isotype

Source

Mouse IgG1

BioLegend

N/A
Rat IgG2b

N/A
BD Biosciences/
BioLegend
BD Biosciences
BD Biosciences
BD Biosciences
BD Biosciences/
BioLegend
BD Biosciences/
BioLegend
BioLegend
BioLegend

Rat IgG2b
Rat IgM
Rat IgG2b
Hamster IgG
Hamster IgG-LEAF
Rat IgG2A

FC, flow cytometry; Neut, neutralization; biotin+, biotinylated.

recruitment at day 7 p.i. with numerous GFP+ cells displaying
microglial morphology. Microglial cell recruitment from the
periphery was confirmed by the abundance of CD45int
CD11b+GFP+ microglia isolated from day 7 p.i. cFMS-EGFP
chimeras by flow cytometry. Furthermore, we found that most
of these microglia expressed Gr1 at similar levels to those
seen on circulating inflammatory monocytes, whereas a large
majority of resident (GFP⫺) microglia did not.
It has been shown that irradiation of the CNS may alter
patterns of monocyte trafficking into the brain in synthetic
models of CNS inflammation (10). Therefore, ability of
Ly6Chi monocytes to traffic to the WNV-infected CNS in
nonirradiated mice was confirmed using two different tracking
techniques. First, we showed that adoptively transferred
Ly6Chi BM-derived monocytes trafficked preferentially to the
WNV-infected CNS, compared with Ly6Clo BM-derived
monocytes. Although it may be argued that the use of BMderived monocytes rather than blood-derived monocytes may
skew the interpretation of our results, it is important to note
that the outcome of the experiment further supports the role
of inflammatory monocytes as microglial precursors. This is
because Ly6Chi inflammatory monocytes also act as precursors
for circulating monocytes, in which case they down-regulate
Ly6C as they circulate (14, 49).
Furthermore, we stably labeled Ly6Chi inflammatory monocytes using a previously described method (14). We found
during WNV encephalitis that FITC bead–labeled monocytes trafficked into the WNV-infected brain and developed
a microglial phenotype, as determined by the expression of
CD45, MHC-II, and CD86. Therefore, these data not only
clearly show that inflammatory monocytes, rather than circulating monocytes, act as microglial precursors during WNV
encephalitis but that inflammatory monocyte migration into
the CNS does not require radiation preconditioning or obvious
BBB disruption (10). Although our data conflict with previous reports showing that irradiation plays a critical role in the
2332

migration of monocyte-derived microglia, other studies suggest that irradiation does not cause any pathological changes
in the brain (54, 55). Furthermore, the employment of head
protection during irradiation not only protects the CNS from
irradiation but also the large volume of blood within the
brain, as well as the BM within the skull (56, 57). Although
it remains to be seen what role these elements play in trafficking of monocytes into the brain, the findings outlined here in
nonirradiated mice indicate that inflammatory monocyte
trafficking is an event triggered by viral encephalitis, a scenario that has not previously been explored in this context.
Finally, similar increases in microglia are observed during WNV infection in mice devoid of the fractalkine receptor CX3CR1 (unpublished data), which further implicates
inflammatory monocytes as microglial precursors. However, as CX3CR1 is expressed constitutively by resident
microglia in the brain (58), further investigation into the
relationship between microglia and CX3CR1+-circulating
monocytes is needed.
The trafficking of inflammatory monocytes has been linked
to the expression of CCR2 and production of CCL2 (15, 16).
WNV infection of the CNS resulted in significant amounts of
CCL2 production. Neutralization of CCL2 resulted in a massive reduction of GFP+ microglia in WNV-infected brains,
clearly showing that the migration of inflammatory monocytes
into the CNS is directed in part by the CCL2-CCR2 axis.
However, the small number of GFP+ cells that are still found
to penetrate the WNV-infected brain after CCL2 neutralization suggests that the other CCR2 ligands, CCL7 and CCL12,
may also play a role in this model (15, 16).
Investigation into the effects of CCL2 neutralization during WNV encephalitis on BM and circulating monocyte
populations showed that CCL2 neutralization resulted in the
retention of Ly6Chi monocytes both in the BM and circulating blood. This suggests, as shown previously in peripheral
nonviral models, that CCL2 acts both at the level of BM
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(that are also likely to be derived from inflammatory monocytes) or CCR2-expressing T cells in the pathogenesis of
WNV encephalitis. However, work conducted by several independent groups suggests that macrophages and T cells, recruited in a CCR5-dependent manner, are important in viral
clearance and do not drive immunopathology (19).
In conclusion, this is the first study to show that microglia
are derived from inflammatory monocytes using CCL2 during a fatal model of flaviviral encephalitis. These exogenously
derived microglia appear to bolster the endogenous microglial population. This CCL2-dependent migration appears to
play a role in the pathogenesis of disease, as CCL2 neutralization prolonged the life of infected mice. The role of infiltrating inflammatory monocytes in mediating immunopathology
during WNV encephalitis requires further investigation;
however, their peripheral location before migration to the
brain suggests that modulating these cells may serve as a novel
therapy, not only during encephalitic disease but during other
CNS disorders also.
MATERIALS AND METHODS
Virus propagation. As previously described (62), WNV (Sarafend) was
derived from the brains of neonatal mice, which were used to infect confluent vero cell monolayers, at a multiplicity of infection of 5 PFU per cell. Infected cells were incubated for 40 h, after which they were frozen. Flasks
were then thawed and the virus-rich supernatant clarified by centrifugation,
after which aliquots were stored at ⫺70°C until use.
Mice and infection. 8–16-wk-old female C57BL/6 (CD45.2) and congenic B6.SJL-PtprcaPep3b/BoyJ (CD45.1), C57BL/6-7.2fms-EGFP transgenic (CD45.2) mice were obtained from the Blackburn animal house
(University of Sydney, Sydney, Australia) or the Animal Resources Center
(Western Australia). All procedures were performed with permission of the
University of Sydney Animal Ethics Committee. All animals were housed
under class II biohazard conditions in hepa filter-top cages. Food and water
was provided ad libitum.
Intranasal infection was conducted as previously described with WNV
6 × 104 PFU in sterile PBS (Invitrogen). Sham infections were conducted by
inoculating with sterile PBS only (62, 64).
Mice were killed using cardiac perfusion of anaesthetised mice with
40 ml of ice-cold PBS followed by perfusion with 20 ml of 4% PFA (SigmaAldrich) in PBS for histology or 50 ml PBS only for flow cytometry.
Plaque assay to determine viral titer. A virus plaque assay with virally
susceptible BHK cells (donated by G. Karupiah, John Curtin Medical
School, Canberra, Australia) was used. Tissue samples were dissected from
animals and were immediately frozen in liquid nitrogen. 10% (wt/vol) tissues homogenates were prepared in Roswell Park Memorial Institute 1640
media (RPMI; CSL Biosciences) immediately before virus titration. In
brief, thawed tissue samples were weighed in 2-ml screw cap tubes
(SARSTEDT) before being disassociated with a power homogenizer (Tissue Tearor; BioSpec). The homogenates were then clarified by centrifugation at 1,500 rpm for 5 min at 4°C. The homogenate supernatant was used
to infect BHK cells. Blood was collected from mice via the brachial artery.
The samples were allowed to sit at 4°C for 8 h to coagulate before serum
and plasma were separated by a high-speed 12,000 rpm centrifugation at
4°C. Supernatant serum was collected from centrifuged samples and stored
in aliquots at ⫺70°C.
BHK cells were seeded into 6-well plates at 1 × 106 cells per well in
2 ml RPMI overnight at 37°C in a 5% CO2 incubator. Media was removed
from the cells and replaced with 150 μl of virus samples at various dilutions.
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egress and also at the BBB interface (15, 16). It appears that
the single-pulse antibody-mediated systemic reduction of the
very high levels of CCL2, in the face of the high throughput
of monocytes from the BM to the brain at this time point,
may reduce immigration of monocytes into the brain before
the effect of BM egress is apparent, causing an increase in
blood monocyte numbers, which is in contrast to the effect
of genetic absence of CCL2 (15).
The infiltration of CD11b+CD45+ myeloid cells has been
implicated in the pathogenesis of WNV disease (21, 22). This
has been argued to be because of infected infiltrating cells acting in a Trojan horse manner, enabling WNV entry from the
periphery into the brain in association with breakdown of the
BBB (21, 22, 59, 60). However, more recently it has been
shown that WNV entry into the CNS is mediated via axonal
transport (61), and integrity of the BBB does not necessarily
predict disease outcomes (45). In our model of intranasal WNV
infection, infectious virus can be isolated from the brain several
days (day 3 p.i) before monocyte infiltration occurs (61, 62),
which is consistent with the expression of CCL2 by infected
neurons attracting monocytes into the brain from the bloodstream. Therefore, the observation that CCL2 neutralization
prolongs the survival of infected mice, although apparently
having no effect on viral titer, suggests that inflammatory
monocyte-derived microglia are likely to play a pathogenic
role in WNV encephalitis, which is not simply explained by
their possible role in viral dissemination (61, 62).
It could be argued that the intranasal model of WNV infection is irrelevant in not mimicking natural infection. However, in all the published models of peripheral inoculation, the
significant peripheral immune activation makes it impossible
to separate the contribution of the systemic immune response
to brain pathology that leads to death from the direct contribution of systemic immune response to death, independently
of brain involvement. This is an important distinction that
needs to inform interventional approaches to disease. The necessity of distinguishing experimentally between pathological
events in the periphery and those in the brain has directed our
development of this model. Furthermore, this distinction is
likely to explain why macrophage deletion in peripheral inoculation results in enhanced mortality, whereas in our model
it increases survival (63).
The exact role of microglia in immune-mediated pathology during WNV infection requires further investigation.
Although it is likely that microglia secrete numerous proinflammatory cytokines, because we have shown the importance of glutamate excitotoxicity during WNV infection, we
suggest that pathogenic functions of microglia may reside in
differential roles of immigrant and resident microglia in regulating neuronal function. Although much work is required to
prove this, when considering the exclusively neuronal localization of WNV (62) and the importance of microglia in regulating the neurological environment, it is not unreasonable
to speculate that inflammatory monocyte-derived microglia
may play a pathogenic role in this phenomenon. Our data cannot definitively rule out an important role for macrophages
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For tissue samples, fivefold dilutions were prepared, whereas serum samples
were titrated twofold only. One well per plate was reserved as a negative
control. Plates were incubated and rocked every 15 min for 1 h at 37°C. The
inoculum was removed by aspiration and the wells overlaid with 3 ml of
1.5% (wt/vol) low-gelling Agarose II (Amresco) in 2× MEM (Invitrogen).
The agarose plugs were allowed to solidify before plates were incubated for
a further 3 d at 37°C. After this period, wells were fixed with 3 ml of 10%
formalin (Sigma-Aldrich) for 2 h before agarose plug removal. Fixation was
necessary to kill free virus and to harden the agarose plug to facilitate removal. A 3% crystal violet (Hopkins and Williams) dye solution in 20%
methanol (Fronine) was used to stain fixed cells. Excess crystal violet was
washed off with PBS. Plates were dried overnight before plaques were
counted using a colony counter (IUL, S. A.). The final PFU per gram (tissue) or milliliter (serum) was determined by factoring the number of plaques,
the inoculum volume, and the dilution.

Clodronate liposome depletion and FITC bead labeling of circulating monocytes. As previously shown, clodronate-encapsulated liposomes
is an efficient method for depleting circulating macrophages (65–67). Clodronate was a gift of Roche. It was encapsulated in liposomes as described
previously, and PBS-encapsulated liposomes were used as controls (65–67).
Macrophages were depleted with multiple injections of clodronate-encapsulated liposomes on days 1, 3, and 5 after WNV infection. In the case of liposome tracking experiments, liposomes containing PBS were labeled with Dil
(Invitrogen) and injected intravenously on day 7 p.i.
To label circulating monocytes, the previously described protocol (14,
50) was modified. C-L liposomes were injected i.v. on day 5.5 p.i. 12 h later,
a second i.v. injection of FITC Flouresbrite polystyrene beads (Polyscience)
diluted 1:25 in PBS was given. Control nonclodronate liposome treatment
groups injected with PBS only or beads only were also used.
Immunohistology. As previously described (62), perfused brains and spleens
were processed into paraffin blocks for sectioning. Sagittal 8-μm sections
were cut for both routine H&E staining and IHC.
Antigen retrieval for WNV labeling was conducted as previously described (62). Antigen retrieval for lectin labeling was conducted using citrate
buffer in a microwave oven set on 600 W for 8 min and allowed to cool for
25 min. Staining protocols for WNV antigen and lectin were identical and
as previously described (62).
Fluorescence IHC was performed for the Gr1 complex with biotinylated Gr1 antibody (BioLegend) on cFMS-EGFP chimeras. In this case, brain
tissue was fixed in 4% PFA at 4°C for 4 h and then immersed in 30% sucrose
overnight, before being frozen in optimum cutting temperature compound
(OCT; Tissue-Tek). 8-μm tissue sections were cut on a cryostat microtome
and air dried. Fluorescence IHC was performed as previously described (62)
with the addition of a tyramide-based amplification system (TSA kit; PerkinElmer) used according to the manufacturer’s instructions.
The presence of D-L liposomes was investigated on frozen 8-μm brain
and spleen sections. In addition, slides were incubated with FITC-conjugated lectin (Sigma-Aldrich) for 60 min before counter stain with DAPI antifade (Vector Laboratories).
BrdU incorporation. To detect proliferating cells, mice received 75 mg/
kg BrdU (Becton Dickinson) i.v. 3 h before sacrifice on days 6 and 7 p.i.
Proliferating cells were detected in situ by IHC using an anti-BrdU antibody
on paraffin-embedded tissues (Skybio), as previously described (68). BrdU2334

Microscope and image acquisition. Images were acquired on a microscope (BX-51; Olympus), using a camera (DP-70; Olympus) and DP manager 2.2.1 software (Olympus).
In-situ hybridization for CCL2. Paraffin-embedded sections were incubated with P33-labeled cRNA probes transcribed from linearized plasmid
constructs containing the CCL2 cDNA and processed for in situ hybridization histochemistry as described previously (61).
CNS leukocyte isolation. As previously described (69), leukocytes were
obtained from the brains of infected mice by digesting brains in PBS with
DNase (0.005 g/ml; Sigma-Aldrich) and collagenase IV (0.05 g/ml; SigmaAldrich) for 60 min at 37°C. Digestion was stopped with 10% FCS. The
subsequent homogenate was passed through a nylon cell strainer with a 70-μm
mesh size (Becton Dickinson). The pellet, obtained after 10-min centrifugation at 340 g, was resuspended in 30% percoll (GE Healthcare) and layered
over 80% Percoll. Leukocytes were collected from the 30/80% interface after centrifugation at 1,140 g for 25 min at room temperature.
BM-derived monocyte and peripheral blood monocyte isolation.
For flow cytometry analysis, the right femur was dissecting out and BM cells
flushed out using PBS-loaded syringes. In the case of BM precursor isolation,
femurs and tibias from at least four mice were used. The cellular suspension
achieved after flushing was filtered through a 70-μm cell strainer and centrifuged for 5 min at 340 g. The red cells in the resulting pellet were lysed in
NH4Cl⫺ red cell lysis buffer before being centrifuged for 5 min at 340 g. In
the case of peripheral blood, blood was collected via cardiac puncture immediately into citrate buffer (mmol; Sigma-Alrich). The resulting suspension
was layered over 30% percoll and centrifuged at 1,140 g for 20 min at room
temperature with the brake off. The interface was collected and the cells
were washed once in PBS and centrifuged at 340 g.
Flow cytometry. Cells collected as described in the previous section from
brain, blood, or BM were then washed in PBS and blocked with antiCD16/CD32 (BioLegend) antibody. Viable cells were counted using trypan
blue exclusion, which routinely showed >95% cell viability. The antibodies
utilized for flow cytometry are outlined in Table I.
Cell surface molecule expression was measured and cell sorts were performed on a FACS ARIA (Becton Dickinson), equipped with an Argon ion
and HeNe laser. Viable populations were gated by forward and side scatter
and identified fluorescent populations determined by forward-gating thereafter. Sorting was performed using specific fluorescent and scatter parameters
identifying the population of interest. Sorting stringencies was set to purity
to achieve >98% purity for BM populations.
Acquired FACS data files were analyzed using the flow cytometry program Flow Jo (Tree Star, Inc.). Quantification of cell populations of interest
were calculated based on flow cytometry percentages at analysis and absolute
cell counts from each organ.
Adoptive transfer. We sorted both Ly6Chi/cFMS-EGFP+/CD11b+ and
Ly6Clo/Cfms-EGFP+/CD11b+ populations from day 6 intranasally WNVinfected mice. Ly6Chi BM was labeled with 10 mM cell tracker orange
(CMTMR [5-(and -6)-(((4-chloromethyl) benzoyl) amino) tetramethylrhodamine)-mixed isomers; Invitrogen). In brief, sorted cells were centrifuged and raised in 1 ml PBS containing 10 μM CMTMR. Cells were
stained for 10 min before the reaction was stopped with 10% FCS. Cells
were washed in 50 ml PBS at least three times. Labeled CMTMR Ly6Chi
BM cells were then mixed 1:1 with Ly6Clo cells, which, except for the addition of CMTMR, had been treated similarly to Ly6Chi populations. A total
of 2 × 106 BM cells were i.v. injected into either day 6.5 WNV-infected or
mock-infected Ly5.1-C57BL/6 congenic mice. 12 h later, brains were
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Generation of chimeric mice. 6–8-wk-old B6.SJL-PtprcaPep3b/BoyJ
(CD45.1) mice were irradiated with one dose of 950 rads. 12 h later, mice
were reconstituted with 107 donor BM cells from C57BL/6-7.2fms-EGFP
BM. Mice were given sulfamethoxazole (Sigma-Aldrich) and trimethoprim
(Sigma-Aldrich) in drinking water for 10 d after irradiation. 6–12 wk after
irradiation, mice were infected with WNV as described in Mice and infection. Chimerism was checked using flow cytometry and was invariably found
to be 96–99% of donor origin (Fig. S5).

positive cells were enumerated throughout the entire brain parenchyma on
eight brains, two sections per brain, at days 6 and 7 p.i. from whole sagittal
brain sections on double-blinded glass slides.
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harvested as described in Mice and infection and CNS leukocyte isolation,
and the presence of donor cells was investigated using flow cytometry, both
using cFMS-EGFP and CMTMR–cell tracker orange.
CCL2 ELISA and neutralization. As previously described (62), cytokine
bead arrays (Becton Dickinson) were used to measure CCL2 protein concentration in both serum and brain homogenates according to the manufacturer’s instructions. CCL2 neutralization was conducted by giving 100 μg
CCL2 (clone: 2H5; BioLegend) or isotype control (Hamster IgG; BioLegend) antibody injections i.p. late on days 5 and 6 consecutively. Late day 7
mice were killed and perfused, and PBMS, BMMC, and infiltrating CNS
leukocytes were prepared as described as described in Mice and infection and
CNS leukocyte isolation.

Online supplemental material. Fig. S1 shows Lectin and NS-1 IHC on
day 7 p.i. throughout the brain. Fig. S2 shows control labeling for BrdU
by flow cytometry in microglia and T cells in the brain and CD11b+ cells
in BM in infected mice and in vitro–activated splenocytes. Fig. S3 shows
Evans blue staining of the brain in WNV infection. Fig. S4 shows depletion
of Ly6Chi and Ly6Clo monocytes in vivo by clodronate liposomes. Fig. S5
shows the purity of the cFMS-EGFP chimeras. Fig. S6 shows that acute
CCL2 neutralization of mock-infected mice has no effect on monocyte
populations. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20080421/DC1.
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